Molecular Partners Ag (MOLN) Receivables (2020 - 2025)

Molecular Partners Ag (MOLN) has disclosed Receivables for 6 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • Quarterly Receivables fell 12.32% to $2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, down 12.32% year-over-year, with the annual reading at $2.3 million for FY2025, 15.12% down from the prior year.
  • Receivables for Q4 2025 was $2.4 million at Molecular Partners Ag, down from $2.7 million in the prior quarter.
  • The five-year high for Receivables was $28.0 million in Q4 2021, with the low at $1.1 million in Q4 2022.
  • Average Receivables over 5 years is $7.3 million, with a median of $2.4 million recorded in 2025.
  • The sharpest move saw Receivables skyrocketed 541.9% in 2021, then plummeted 95.94% in 2022.
  • Over 5 years, Receivables stood at $28.0 million in 2021, then tumbled by 95.94% to $1.1 million in 2022, then surged by 100.43% to $2.3 million in 2023, then rose by 20.06% to $2.7 million in 2024, then fell by 12.32% to $2.4 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $2.4 million, $2.7 million, and $2.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.